scholarly journals Characteristics of patients treated for severe hypoglycaemia in emergency care settings – Analysis of routinely collected data

2019 ◽  
Vol 43 ◽  
pp. 74-78
Author(s):  
Anita Keller-Senn ◽  
Geraldine Lee ◽  
Lorenz Imhof ◽  
Jackie Sturt
2019 ◽  
Vol 9 (3) ◽  
pp. 107-112
Author(s):  
J. Gil Cuesta ◽  
M. Trelles ◽  
A. Naseer ◽  
A. Momin ◽  
L. Ngabo Mulamira ◽  
...  

Introduction: Conflicts frequently occur in countries with high maternal and neonatal mortality and can aggravate difficulties accessing emergency care. No literature is available on whether the presence of conflict influences the outcomes of mothers and neonates during Caesarean sections (C-sections) in high-mortality settings.Objective: To determine whether the presence of conflict was associated with changes in maternal and neonatal mortality during C-sections.Methods: We analysed routinely collected data on C-sections from 17 Médecins Sans Frontières (MSF) health facilities in 12 countries. Exposure variables included presence and intensity of conflict, type of health facility and other types of access to emergency care.Results: During 2008–2015, 30,921 C-sections were performed in MSF facilities; of which 55.4% were in areas of conflict. No differences were observed in maternal mortality in conflict settings (0.1%) vs. non-conflict settings (0.1%) (P = 0.08), nor in neonatal mortality between conflict (12.2%) and non-conflict settings (11.5%) (P = 0.1). Among the C-sections carried out in conflict settings, neonatal mortality was slightly higher in war zones compared to areas of minor conflict (P = 0.02); there was no difference in maternal mortality (P = 0.38).Conclusions: Maternal and neonatal mortality did not appear to be affected by the presence of conflict in a large number of MSF facilities. This finding should encourage humanitarian organisations to support C-sections in conflict settings to ensure access to quality maternity care.


Health Equity ◽  
2021 ◽  
Vol 5 (1) ◽  
pp. 801-817
Author(s):  
Kevin Morisod ◽  
Xhyljeta Luta ◽  
Joachim Marti ◽  
Jacques Spycher ◽  
Mary Malebranche ◽  
...  

2020 ◽  
Vol 44 (6) ◽  
Author(s):  
Harald Dormann ◽  
Patrick Andreas Eder ◽  
Henner Gimpel ◽  
Oliver Meindl ◽  
Asarnusch Rashid ◽  
...  

1979 ◽  
Vol 24 (8) ◽  
pp. 663-664
Author(s):  
ALVIN G. BURSTEIN
Keyword(s):  

2005 ◽  
Vol 33 (5) ◽  
pp. 84
Author(s):  
JENNIFER SILVERMAN
Keyword(s):  

1971 ◽  
Vol 67 (2) ◽  
pp. 405-416 ◽  
Author(s):  
E. Nieschlag ◽  
H. Wombacher ◽  
F. J. Kroeger ◽  
L.V. Habighorst

A patient with a metastazing functional islet cell tumour suffering from severe hypoglycaemia was treated with streptozotocin. Four intravenous injections of 1.5 g streptozotocin each were administered in 4 to 6 days intervals. After the 4th injection there were no further episodes of hypoglycaemia, parenteral glucose administration could be stopped and blood sugar and plasma insulin, showing concentrations of up to 405 μU/ml before treatment, reached normal levels. The tumours in the pancreas disappeared and the liver metastases decreased in size and number as judged by arteriography. A hypothesis for the mechanism of action of streptozotocin is proposed. The glucose moiety is considered to facilitate a high affinity to the islet cells whereas the N-methyl-nitrosourea residue serves the active antitumour part of the molecule.


Sign in / Sign up

Export Citation Format

Share Document